Search Videos and More
News
Dana-Farber Research Uncovers Approach to Activating the Immune System Against Metastatic Breast Cancer
Cancer spreads, or metastasizes, when tumor cells shed from a primary solid tumor, for example in the breast, and embed in other organs, such as the lung, liver, and brain, and begin to grow.
Symposium
Our Ambulatory Cell Therapies Clinic
Our growing outpatient cell therapies program enables many patients to receive stem cell transplant and CAR T-cell therapies without a lengthy hospital admission. Through this program, patients receive the same high-quality, comprehensive care – conditioning chemotherapy, cell infusion, and follow-up monitoring – in our Ambulatory Cell Therapies Clinic and return home or to nearby accommodations each day during their treatment period.
News
Dana-Farber Research News 03.01.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from February 1 - 15.
News
Researcher Gains Insight into Rare Genetic Diseases
Rare genetic cancers may affect few people, but their complexity makes them powerful windows into how even the most common cancers develop and behave.
News
Dana-Farber Research News 02.15.2026
This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from January 16 - 31.
News
Dana-Farber, Gustave Roussy to Host Fifth Transatlantic Exchange in Oncology Focused on Cancer Drug Innovation
Dana-Farber Cancer Institute will host the Fifth Transatlantic Exchange in Oncology on Friday, March 27, 2026, bringing together leading cancer researchers and clinicians from the United States and Europe to explore transatlantic innovations in cancer drug research.
News
Making Breakthroughs in ALL From Youth to Adulthood
When Ann Carroll was diagnosed with cancer at age 28, her dream to get married and have a baby felt out of reach. Now, seven years later and cancer-free, she is living that dream with her husband and their 7-month-old son, Teddy.
News
Cell-Death Safety Net a Potential New Cancer Target
In the rare event that an elevator cable breaks, modern buildings have additional fail-safe mechanisms. For example, counterweight and mechanical brakes prevent the car from plummeting to the ground.
News
Dana-Farber Launches Colorectal Cancer Screening Program in Central Asia
Dana-Farber Cancer Institute's Center for Global Health launched the first colorectal cancer screening program in Central Asia this week, partnering with Uzbekistan’s Ministry of Health and National Cancer Center to pilot a sustainable, early detection model that could be scaled across the region.
News
Dana-Farber Research Helps Drive FDA Label Update for Primary CNS Lymphoma
Change removes prior exclusion and may expand access to CAR T-cell therapy for eligible relapsed or refractory patients
News
Dana-Farber’s Largest Single Gift Advances Planned Cancer Hospital for New England
Dana-Farber Cancer Institute today announced the largest single gift in its history through a new joint commitment from Josh and Anita Bekenstein and the Jonathan and Jeannie Lavine family. The transformational gift for the future cancer hospital builds on the two families’ decades-long dedication to Dana-Farber’s mission of delivering expert, compassionate patient care while accelerating discoveries that improve outcomes for people with cancer around the world.
News
Three Dana-Farber Cancer Institute scientific leaders elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026
Dr. Alice Shaw, Dr. Kimberly Stegmaier and Dr. Matthew Vander Heiden have been elected as Fellows of the American Association for Cancer Research (AACR) Academy Class of 2026.